$196.00
0.39 (-0.20%)
Last updated: May 31, 2026 03:57
Fundamentals Overview
Biogen Inc. is near the high of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+252.8% upside vs price
Profitability
Risk (Beta)
0.2 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +252.8% upside vs price · Analyst grade: A- · Sentiment improving (3 upgrades) · 3M vs Healthcare sector: +8.1%
Pressures (Sell):
3M vs S&P 500: -6.4%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Equal Weight: 3, Hold: 3, Market Perform: 1, Neutral: 8, Outperform: 4, Overweight: 3, Reduce: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $691.43; current price is $196.00. That’s a +252.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 21.19 |
| DCF value (model) | $691.43 (252.8% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.55 |
| P/S (TTM) | 2.94 |
| P/FCF (TTM) | 11.03 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.06 |
| Quick Ratio (TTM) | 2.41 |
| Cash Ratio (TTM) | 1.13 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 13.92% |
| Gross margin (TTM) | 69.77% |
| Operating margin (TTM) | 15.65% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for BIIB.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| RBC Capital | maintain | Outperform | Outperform | 2026-05-27 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-05-15 |
| Citigroup | maintain | Neutral | Neutral | 2026-05-01 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-30 |
| RBC Capital | maintain | Outperform | Outperform | 2026-04-30 |
| Guggenheim | maintain | Buy | Buy | 2026-04-30 |
| Wedbush | maintain | Neutral | Neutral | 2026-04-30 |
| UBS | upgrade | Neutral | Buy | 2026-04-22 |
| Wells Fargo | upgrade | Equal Weight | Overweight | 2026-04-20 |
| Piper Sandler | upgrade | Neutral | Overweight | 2026-04-14 |
| Citigroup | maintain | Neutral | Neutral | 2026-04-13 |
| Truist Securities | maintain | Hold | Hold | 2026-04-13 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-10 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-04-02 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-04-01 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-04-01 |
| HSBC | maintain | Reduce | Reduce | 2026-03-17 |
| Freedom Broker | maintain | Hold | Hold | 2026-02-23 |
| Wedbush | maintain | Neutral | Neutral | 2026-02-10 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-09 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-09 |
| Truist Securities | maintain | Hold | Hold | 2026-02-09 |
| BMO Capital | maintain | Market Perform | Market Perform | 2026-02-09 |
| RBC Capital | maintain | Outperform | Outperform | 2026-02-09 |
| Piper Sandler | maintain | Neutral | Neutral | 2026-02-09 |
| JP Morgan | maintain | Neutral | Neutral | 2026-02-09 |
| Wedbush | maintain | Neutral | Neutral | 2026-02-09 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-02-09 |
| Guggenheim | maintain | Buy | Buy | 2026-02-09 |
| TD Cowen | maintain | Buy | Buy | 2026-02-09 |